NEA Management Company as of March 31, 2014
Portfolio Holdings for NEA Management Company
NEA Management Company holds 28 positions in its portfolio as reported in the March 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Groupon | 20.9 | $426M | 54M | 7.84 | |
| Tesaro | 14.3 | $291M | 9.9M | 29.48 | |
| Cvent | 10.6 | $217M | 6.0M | 36.15 | |
| Clovis Oncology | 7.8 | $158M | 2.3M | 69.27 | |
| Epizyme | 7.2 | $147M | 6.4M | 22.77 | |
| Glycomimetics (GLYC) | 6.9 | $140M | 8.6M | 16.33 | |
| Supernus Pharmaceuticals (SUPN) | 4.7 | $95M | 11M | 8.94 | |
| Hyperion Therapeutics | 3.6 | $74M | 2.9M | 25.80 | |
| Fusion-io | 3.6 | $74M | 7.0M | 10.52 | |
| Millennial Media | 2.8 | $57M | 8.2M | 6.92 | |
| InterMune | 2.2 | $45M | 1.3M | 33.47 | |
| Sunesis Pharmaceuticals | 1.8 | $37M | 5.6M | 6.61 | |
| Prosensa Hldgs B V Shs Usd | 1.8 | $37M | 6.5M | 5.63 | |
| Boingo Wireless | 1.5 | $30M | 4.5M | 6.78 | |
| Trevena | 1.5 | $30M | 3.8M | 7.86 | |
| Nektar Therapeutics (NKTR) | 1.1 | $22M | 1.8M | 12.12 | |
| Targacept | 1.1 | $22M | 4.6M | 4.75 | |
| Channeladvisor | 1.0 | $21M | 557k | 37.74 | |
| Lexicon Pharmaceuticals | 1.0 | $20M | 12M | 1.73 | |
| Zhone Technologies | 1.0 | $20M | 4.8M | 4.22 | |
| Alimera Sciences Comstkusd0.01 | 0.9 | $18M | 2.3M | 7.89 | |
| Orexigen Therapeutics | 0.6 | $13M | 1.9M | 6.50 | |
| Rigel Pharmaceuticals | 0.6 | $13M | 3.2M | 3.88 | |
| Amicus Therapeutics (FOLD) | 0.6 | $12M | 5.7M | 2.07 | |
| Exelixis (EXEL) | 0.4 | $7.8M | 2.2M | 3.54 | |
| Transcept Pharmaceuticals | 0.3 | $6.4M | 2.1M | 3.08 | |
| ArQule | 0.2 | $5.2M | 2.5M | 2.05 | |
| NeuroMetrix | 0.0 | $134k | 57k | 2.34 |
